Eledon Pharmaceuticals, Inc. (ELDN)

e.l.f. Beauty posts fiscal fourth quarter sales growth of 35.1% as Rhode boosts results, while margins face pressure from higher operating costs.

On May 20, 2026, the market is set to receive earnings updates from various significant players, including e.l.f. Beauty Inc (ELF), which has a consensus earnin

Despite a 7.7% decline last week, ... analysis, the stock currently appears overvalued relative to its Fair Value, landing it on the Most Overvalued list. InvestingPro offers 11 additional exclusive tips and comprehensive financial metrics for ELDN investors....

Elders (ASX:ELD) has become a focus for investors after its half year FY26 earnings update, which reported higher underlying EBIT, contributions from the Delta Agribusiness acquisition, and a fully franked interim dividend. See our latest analysis for Elders.

The widening gap between top-line expansion and profit pressure marks a sharp reversal from the prior quarter, when e.l.f. posted earnings of $1.24 a share on revenue of $489.5 million, crushing Wall Street expectations. The stock has tumbled to $52.98 from a 52-week high of $150.99, hovering ...